Medexus Pharmaceuticals Inc
TSX:MDP

Watchlist Manager
Medexus Pharmaceuticals Inc Logo
Medexus Pharmaceuticals Inc
TSX:MDP
Watchlist
Price: 2.69 CAD Market Closed
Market Cap: 86.8m CAD

Intrinsic Value

The intrinsic value of one MDP stock under the Base Case scenario is 7.75 CAD. Compared to the current market price of 2.69 CAD, Medexus Pharmaceuticals Inc is Undervalued by 65%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDP Intrinsic Value
7.75 CAD
Undervaluation 65%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Medexus Pharmaceuticals Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
MDP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for MDP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Medexus Pharmaceuticals Inc
TSX:MDP
CA
Pharmaceuticals
Market Cap
86.8m CAD
IPO
Mar 3, 2012
CA
Pharmaceuticals
Market Cap
86.8m CAD
IPO
Mar 3, 2012
Price
CA$false
EPS
$false
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Medexus Pharmaceuticals Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medexus Pharmaceuticals Inc

Current Assets 66.7m
Cash & Short-Term Investments 8.4m
Receivables 14.1m
Other Current Assets 44.1m
Non-Current Assets 79.3m
PP&E 712k
Intangibles 69.3m
Other Non-Current Assets 9.3m
Efficiency

Free Cash Flow Analysis
Medexus Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medexus Pharmaceuticals Inc

Revenue
109.5m USD
Cost of Revenue
-52.1m USD
Gross Profit
57.5m USD
Operating Expenses
-42.4m USD
Operating Income
15m USD
Other Expenses
-11.5m USD
Net Income
3.6m USD
Fundamental Scores

MDP Profitability Score
Profitability Due Diligence

Medexus Pharmaceuticals Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
ROE is Increasing
ROIC is Increasing
50/100
Profitability
Score

Medexus Pharmaceuticals Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

MDP Solvency Score
Solvency Due Diligence

Medexus Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
37/100
Solvency
Score

Medexus Pharmaceuticals Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDP Price Targets Summary
Medexus Pharmaceuticals Inc

Wall Street analysts forecast MDP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDP is 6.24 CAD with a low forecast of 3.48 CAD and a high forecast of 10.5 CAD.

Lowest
Price Target
3.48 CAD
30% Upside
Average
Price Target
6.24 CAD
132% Upside
Highest
Price Target
10.5 CAD
290% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Medexus Pharmaceuticals Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for MDP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one MDP stock?

The intrinsic value of one MDP stock under the Base Case scenario is 7.75 CAD.

Is MDP stock undervalued or overvalued?

Compared to the current market price of 2.69 CAD, Medexus Pharmaceuticals Inc is Undervalued by 65%.

Back to Top